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The theoretical model of Brown and Barlow (2009) of the 
classifi cation of emotional disorders emphasizes the similarities of 
anxiety and mood disorders and suggests that emotion regulation 
plays an important role in the psychopathology of these psychological 
disorders (Campbell-Sills & Barlow, 2007; Gross, 2007). These 
authors propose a common classifi cation for them (Barlow, 1991, 
2002). The similarity in psychopathology is due to two genetically 
established temperament dimensions that determine the aetiology 
and course of emotional disorders: Neuroticism/negative affect 
and extraversion/positive affect. The scientifi c literature supports 
the role of these vulnerability constructs in the onset, overlap, and 
maintenance of anxiety and mood disorders (e.g., Barlow, 2002; 
Brown, 2007; Blanco et al., 2013). 
Researchers who have studied personality characteristics from 
a clinical model have found a high prevalence of personality 
disorders (PeD) in panic disorder (PD) and panic disorder with 
agoraphobia (PDA) samples, which shows the close relationship 
between both mental disorders. Recent studies provide data on 
comorbidity ranging between 33.3 and 76.8% (Albert, Maina, 
Bergesio, & Bogetto, 2006; Iketani et al., 2004; Marchesi, Cantón, 
Fonito, Giannelli, & Maggini, 2005; Marchesi et al., 2006). As we 
can see, there is unanimity in linking PeD with PD/PDA although 
there is also a high variability in prevalence rates. With respect to 
the specifi city of the PeD found in clinical samples of PD/PDA, 
researchers have found a close relationship between cluster C and 
PD/PDA, particularly with avoidant PeD (Iketani et al., 2004; 
Telch, Kamphuis, & Schmidt, 2011), dependent PeD (Albert et 
al., 2006; Starcevic et al., 2008) and obsessive-compulsive PeD 
(Marchesi et al., 2005, 2006). With regard to the hypothesis that 
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Abstract Resumen
Background: No studies have been found that compared the 
psychopathology features, including personality disorders, of Panic 
Disorder (PD) and Panic Disorder with Agoraphobia (PDA), and a 
nonclinical sample with anxiety vulnerability. Method: The total sample 
included 152 participants, 52 in the PD/PDA, 45 in the high anxiety 
sensitivity (AS) sample, and 55 in the nonclinical sample. The participants 
in PD/PDA sample were evaluated with the structured interview ADIS-
IV. The Brief Symptom Inventory and the MCMI-III were used in all 
three samples. Results: Statistically signifi cant differences were found 
between the PD/PDA and the nonclinical sample in all MCMI-III scales 
except for antisocial and compulsive. No signifi cant differences were 
found between PD/PDA and the sample with high scores in AS. Phobic 
Anxiety and Paranoid Ideation were the only scales where there were 
signifi cant differences between the PD/PDA sample and the high AS 
sample. Conclusions: Our fi ndings showed that people who scored high 
on AS, despite not having a diagnosis of PD/PDA, were similar in regard to 
psychopathology features and personality to individuals with PD/PDA.
Keywords: Panic disorder, panic disorder with agoraphobia, anxiety 
sensitivity, personality disorders, MCMI-III.
Trastornos de personalidad en pacientes con trastorno de pánico y en 
personas con alta sensibilidad a la ansiedad. Antecedentes: no se han 
encontrado estudios que comparen variables psicopatológicas, incluyendo 
trastornos de personalidad, entre pacientes con Trastorno de pánico (TP) 
y Trastorno de pánico con agorafobia (TPA), y una muestra no clínica 
con vulnerabilidad a la ansiedad. Método: la muestra total fue de 152 
participantes, 52 en la muestra de TP/TPA, 45 en la muestra no clínica 
con alta sensibilidad a la ansiedad (SA) y 55 en la no clínica con baja SA. 
Los participantes con TP/TPA fueron evaluados a través de la entrevista 
estructurada ADIS-IV. Administramos el Inventario Breve de Síntomas y 
el MCMI-III en las tres muestras. Resultados: se encontraron diferencias 
estadísticamente signifi cativas entre la muestra con TP/TPA y la no clínica 
con baja SA en todas las escalas salvo en la antisocial y compulsiva. No 
encontramos diferencias signifi cativas entre la muestra con TP/TPA y la 
muestra no clínica con alta SA. Las únicas escalas psicopatológicas que 
diferencian las muestras clínica y con alta SA fueron la Ansiedad Fóbica 
y la Ideación Paranoide. Conclusiones: nuestros resultados muestran que 
las personas que puntúan alto en SA, a pesar de no tener un diagnóstico 
de TP/TPA, son muy similares a los pacientes con TP/TPA en variables 
psicopatológicas y de personalidad.
Palabras clave: trastorno de pánico, trastorno de pánico con agorafobia, 
sensibilidad a la ansiedad, trastornos de personalidad, MCMI-III.
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pathological personality traits constitute risk factors for PD/PDA, 
Bienvenu et al. (2009), indicated that features such as avoidant, 
dependent, and other related traits (i.e., shyness), predict the onset 
of PD, AG, or both.
The high percentages of PeD and specifi c personality 
pathological profi les (cluster C), and the presence of high levels of 
neuroticism and lower levels of extraversion in PD/PDA samples 
(Carrera et al., 2006; Kotov, Gamez, Schmidt, & Watson, 2010) 
corroborate Brown and Barlow’s (2009) theory on temperamental 
vulnerability factors of higher order in emotional disorders. 
Besides the temperamental vulnerability factors described, 
other vulnerability factors have been proposed as playing a role 
in the onset, course and maintenance of PD/PDA, such as anxiety 
sensitivity (AS – Drost et al., 2012; Schmidt et al., 2010; Weems, 
Costa, Watts, Taylor, & Cannon, 2007). AS refers to the tendency 
to respond with fear to anxiety-related sensations (Reiss, Peterson, 
Gursky, & McNally, 1986). Maller and Reiss (1992) were the fi rst 
authors to explore whether people with high AS are at risk of 
developing PD. To answer this question, they conducted a three-
year follow-up study with 151 high school students without PD 
history and found that Anxiety Sensitivity Index scores (ASI; 
Reiss et al., 1986) at baseline predicted the frequency and intensity 
of panic attacks in the follow-up period. In addition, participants 
with higher levels of AS were fi ve times more likely to develop an 
anxiety disorder. Since this study, many others have confi rmed 
that people who score high on the ASI are at increased risk for 
experiencing panic attacks compared with those who score lower 
(Plehn & Peterson, 2002).
The aim of this study is to explore the similarities and 
differences in personality pathology and clinical features among 
three different samples, PD/PDA sufferers, a non-clinical sample 
with high levels of AS, and a non-clinical sample with low levels 
of AS. If people with high scores on the ASI are at greater risk of 
developing anxiety and panic (Plehn & Peterson, 2002), and there 
are specifi c personality features linked to PD/PDA individuals, we 
hypothesized that the personality profi le of the sample with high 
levels of AS will be more similar to that of people with a diagnosis 
of PD/PDA than people without clinical pathology and low levels 
of AS. We consider that this type of studies may be relevant to 
shed further light on the study of risk factors in PD/PDA. 
Method
Participants
 
The total sample was composed of 152 participants (52 in 
the PD/PDA sample, 55 in the non-clinical sample with low AS 
scores and 45 in the sample with high AS scores). Table 1 shows 
the composition and demographic characteristics of the three 
groups. Group comparisons indicated the existence of statistically 
signifi cant differences in age and employment status. 
Instruments
 
Data from the following measures were collected:
Anxiety Disorders Interview Schedule. The ADIS-IV (Brown 
et al., 1994) is a structured diagnostic interview designed to 
comprehensively evaluate anxiety disorders according to the 
DSM-IV-TR (2000). Test-retest reliability varies, depending on 
the study, from .68 to 1. The ADIS-IV is a useful interview that 
exhaustively traces the symptoms of anxiety and is sensitive to 
changes after treatment (Antony & Swinson, 2000). 
Anxiety Sensitivity Index. The ASI (Reiss et al., 1986; Spanish 
version by Sandín, Chorot, & McNally, 1996) is a questionnaire 
containing 16 items that measure fear of anxiety symptoms. Each 
item is rated along a 5-point Likert scale ranging from 0 (very 
little) to 4 (very much). There is good evidence of the reliability 
and validity of the ASI with a Cronbach’s alpha of .84.
Brief Symptom Inventory. The BSI (Derogatis & Melisaratos, 
1983; validated for Spanish population by Ruipérez et al., 2001) 
is a 49-item inventory measuring general psychopathology. It 
provides information on 6 subscales: Depression, phobic anxiety, 
paranoid ideation, obsession-compulsion, somatization, and 
hostility/aggressivity. Responses are obtained through a 5-point 
Likert scale ranging from 0 (none) to 4 (much). The different 
scales offer high reliability in non-clinical samples (Cronbach’s 
alpha ranging from .70 to .91).
Millon Clinical Multiaxial Inventory-III. The MCMI-III 
(Millon, Davis, & Millon, 2007; adapted and validated for Spanish 
population by Cardenal & Sánchez, 2007). The MCMI-III consists 
of 175 items and provides a profi le according to 14 scales: Schizoid, 
avoidant, depressive, dependent, histrionic, narcissistic, antisocial, 
aggressive, compulsive, negativistic, self-defeating, schizotypal, 
borderline, and paranoid. Prevalence scores equal to or higher 
than 75 indicate the presence of personality traits, and equal to or 
higher than 85 indicate the presence of a personality disorder. The 
MCMI-III has shown good psychometric properties.
Procedure
 
In Figure 1, we offer the participant fl ow. Participants in the 
clinical sample (n = 80) were invited to participate in the study 
when they were going through the assessment in their clinical 
Table 1
Sociodemographic data in the different study groups
 Clinical
PD/PDA
Non-clinical
High AS 
Non-clinical
Low AS
Number 52 45 55
Sexa
Male
Female
26 (50.0%)
26 (50.0%)
15 (33.3%)
30 (66.7%)
21 (38.2%)
34 (61.8%)
Mean ageb* (SD) 32 (10.4) 26.9 (9.4) 31.8 (8.2)
Marital statusa
Never married
Married
Divorced or separated
31 (59.6%)
18 (34.6%)
3 (5.8%)
35 (77.8%)
10 (22.2%)
0 (0%)
28 (50.9%)
23 (41.8%)
4 (7.3%)
Educationa
Elementary school
High-school
University degree
3 (5.8%)
20 (38.5%)
29 (55.8%)
3 (6.67%)
9 (20%)
33 (73.33%)
6 (10.9%)
11 (20.0%)
38 (69.1%)
Occupational levela*
Unemployed
Student
Unskilled labor
Skilled labor
4 (7.7%)
14 (26.9%)
20 (38.5%)
14 (26.9%)
1 (2.22%)
27 (60.0%)
8 (17.8%)
9 (20.0%)
2 (3.6%)
14 (25.5%)
19 (34.5%)
20 (36.4%)
a Independence tested with a χ2 test; b mean differences tested with a one-way ANOVA;
* p<.05; AS: Anxiety Sensitivity
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center (PREVI center in Valencia and Castellón, CREOS, 
centro de psicoterapia y formación [center of psychotherapy and 
formation] in Castellón, and Psychological Assistance Service 
at the Universitat Jaume I in Castellón). All the participants in 
this sample were diagnosed of PD/PDA by the clinicians with the 
ADIS-IV (Brown, et al., 1994). The invitation was made when 
it was confi rmed that they met the inclusion criteria and before 
starting the psychological treatment. The fi nal clinical sample 
included 52 participants, 44 met criteria for PDA and 8 for PD. 
The mean duration of the disorder was 5.0 years (SD = 5.0 years; 
range from 4 months to 17 years). If the participants agreed to 
participate, they voluntarily signed an informed consent. The study 
had the approval of the ethical committees of all the centers who 
participated in this study. The participants fi lled out the MCMI-
III, the BSI and the ASI. 
All participants in the non-clinical samples were undergraduate 
and postgraduate students at Universitat Jaume I and employees 
of different companies in Castellon; all of them were volunteers 
and they signed an informed consent (n = 173). The assessment of 
the non-clinical samples was done by the author J. O. They fi lled 
out the MCMI-III, the BSI and the ASI in a single session. In the 
same session, they were asked whether they had received or were 
receiving psychological or psychiatric treatment.
For all groups under study, the exclusion criterion established 
was being younger than 18 years. Also, for the clinical sample: 
diagnosis of schizophrenia or bipolar I disorder, diagnosis 
of severe organic disease, diagnosis or history of substance 
dependence, diagnosis of mental retardation or developmental 
disorder, and currently receiving psychological treatment for 
PD/PDA. For the non-clinical samples: History or currently 
suffering any psychiatric disorder (this was assessed by a 
question in the assessment protocol). Additionally, to divide the 
non-clinical sample between those with high or low AS, as the 
ASI (Reiss et al., 1986) does not provide a cut-off score, we used 
the range offered by Peterson and Reiss (1992) for non-clinical 
population, between 14.2 and 22.5 to set the cut-off at 23. 
Participants who score equal to or higher than 23 were assigned 
to the non-clinical with high AS sample and participants with 
lower scores than 23 were assigned to the non-clinical with low 
AS sample.  
Data analysis
 
To analyze the data, parametric statistics were used from 
the Statistical Package for Social Sciences (SPSS) 19.0 (SPSS 
19.0, SPSS Inc, Chicago, IL). To compare the samples regarding 
demographics, chi-square statistic was used with categorical 
variables, and analysis of variance (ANOVA) was used to compare 
means. ANOVAs were performed to compare the clinical 
sample and the other study groups in the different measures. 
Completed screening
(n = 253)
Clinical sample
n = 80 (17.22%)
Control sample
n = 173 (68.38%)
Excluded (n = 28; 35%)
– Current depression (n = 5)
– Current psychological treatment (n = 13)
– Incomplete assessment (n = 10)
Excluded (n = 73; 42.19%)
– History of depression or anxiety disorder
(n = 31)
– Current depression or anxiety disorder (n
= 26)
– Incomplete assessment (n = 16)
ASI scores <23
Assigned to low AS sample
ASI scores ≥23
Assigned to high AS sample
Completed assessnent
in low AS sample
n = 55 (31.79%)
Completed assessnent
in hihg AS sample
n = 45 (26.01%)
Completed assessnent
in clinical sample
n = 52 (65%)
Figure 1. Participant fl ow chart
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Homoscedasticity assumption was checked with Levene’s statistic. 
When the hypothesis of equality of means was rejected, p-values 
of the ANOVA were computed with the Welch and Brown 
and Forsythe tests (in all the cases where variances were not 
homogeneous, the conclusion of the hypothesis testing of equality 
of means never changed with the common ANOVA test and the 
robust alternatives). Post-hoc analyses were also performed. 
The test selected was Tukey with a level of p<.05 to determine 
statistical signifi cance. To set the effect size in mean comparisons, 
Cohen’s d tests were performed.
Results
As can be seen in Table 1, there were statistically signifi cant 
differences between the samples in age, F(2, 149) = 4.412, p = .014, 
adjusted R2 = .043, and employment status, χ2(6, N =152) = 17.88, 
p = .007. These differences could be attributed mainly to the fact 
that the high AS sample was composed of university students. The 
mean and standard deviation of the ASI in the PD/PDA sample 
were 30.67 (SD = 11.06), for the high AS sample 25.56 (SD = 2.17) 
and for the non-clinical sample 10.49 (SD = 4.47).
Taking into account the results in personality traits, using 75 
as the cut-off point, 44 participants (80%) in the non-clinical 
sample with low AS presented personality traits in compulsive, 
histrionic, narcissistic and avoidant scales. In the non-clinical 
sample with higher AS, 40 participants (88.89%) obtained scores 
indicating depressive, compulsive, avoidant, dependent and 
histrionic personality traits. Finally, 48 participants (92.31%) 
in the clinical sample obtained scores indicative of avoidant, 
compulsive, histrionic and dependent personality traits. With 
respect to the identifi ed PeD, using 85 as the cut-off point, 3 
participants (21.43%) in the non-clinical sample with low AS 
presented narcissistic, histrionic and obsessive PeD. Only 2 
participants (14.28%) in the non-clinical sample with higher 
AS presented obsessive and avoidant PeD, and 4 participants 
(28.57%) in the PD/PDA sample presented histrionic, obsessive, 
avoidant and paranoid PeD.
The ANOVAs showed statistically signifi cant differences in 
the comparison between the three study samples in all the MCMI-
III personality pathology scales with the exception of antisocial 
and compulsive. The post-hoc tests revealed that the differences 
were only statistically signifi cant in the comparisons between the 
PD/PDA and the non-clinical with high AS scores sample with 
the non-clinical with low AS scores sample. Between the PD/PDA 
and the high AS sample, there were no statistically signifi cant 
differences in any personality disorder scale. Individuals with PD/
PDA, in comparison with the non-clinical with low AS sample, 
showed signifi cant differences in all personality scales except 
for the Antisocial and Compulsive scales. The high AS sample, 
in comparison with the low AS sample, showed signifi cant 
differences in all personality scales except for the Narcissistic, 
Antisocial and Compulsive scales.
Finally, Table 3 shows the means obtained in the BSI (Derogatis 
& Melisaratos, 1983) scales in the three samples and the comparison 
among them. The scores of the non-clinical sample with low AS 
were lower than the scores of the normative group provided by 
the authors of the questionnaire, confi rming that participants 
belonging to this group, although presenting high scores in some 
of the personality pathology profi les of the MCMI-III (histrionic, 
narcissistic, and compulsive), did not present signifi cant symptoms 
of Axis I psychopathology. The average rating for the PD/PDA and 
the high AS sample were very similar (signifi cant differences were 
not found) except for the Phobic Anxiety and Paranoid Ideation 
scales where signifi cant differences were found (p<.001 and p<.05, 
respectively). The scores in the PD/PDA sample were signifi cantly 
higher in Phobic Anxiety and lower in paranoid ideation than the 
ones found in the high AS sample. The comparisons between the 
PD/PDA and the high AS samples with the low AS sample offered 
statistically signifi cant differences in all BSI scales with a high 
effect size (ranging from 0.74 to 2.17).
Table 2
Means, standard deviations, mean differences (Tukey’s statistical) signifi cance and effect size on the MCMI-III in the different study groups
Clinical
PD/PDA
Non-clinical
High AS
Non-clinical
Low AS
PD/PDA–
High AS
PD/PDA–
Low AS 
High AS–
Low AS
Mean (SD) Mean (SD) Mean (SD) F Difference d Difference d Difference d
Squizoid 43.82 (22.59) 42.82 (20.68) 31.58 (19.33) 5.61*** 1.00 0.05 12.24** 0.58 11.24* 0.56
Avoidant 53.78 (25.63) 54.73 (20.31) 29.76 (25.23) 18.20*** -0.94 -0.04 24.03*** 0.94 24.97*** 1.09
Depressive 46.75 (21.46) 49.35 (26.90) 19.56 (18.40) 28.80*** -2.60 -0.10 27.18*** 1.36 29.79*** 1.19
Dependent 52.30 (22.30) 54.02 (20.07) 30.47 (19.48) 21.14*** -1.71 -0.08 21.83*** 1.04 23.55*** 1.19
Histrionic 46.94 (24.94) 40.73 (22.38) 59.25 (17.26) 9.63*** 6.21 0.26 -12.31* -0.57 -18.52*** -0.93
Narcissistic 51.51 (15.30) 54.75 (17.12) 61.94 (17.40) 5.51** -3.24 -0.20 -10.43*** -0.64 -7.19 -0.42
Antisocial 40.69 (20.65) 46.29 (18.06) 38.47 (20.97) 1.95 -5.59 -0.29 2.22 0.11 7.81 0.4
Agressive 44.28 (19.24) 45.95 (19.66) 30.98 (21.71) 8.53*** -1.67 -0.08 13.31*** 0.65 14.97*** 0.72
Compulsive 57.84 (16.61) 51.02 (20.09) 59.40 (20.37) 2.61 6.82 0.37 -1.55 -0.08 -8.38 -0.41
Negativistic 46.30 (22.70) 52.89 (17.68) 31.93 (18.95) 14.68*** -6.58 -0.32 14.38*** 0.69 20.96*** 1.14
Self-defeating 38.80 (26.04) 41.27 (22.36) 15.44 (18.09) 21.30*** -2.46 -0.1 23.37*** 1.04 25.83*** 1.27
Squizotypal 39.36 (24.57) 44.58 (21.49) 17.02 (18.67) 23.62*** -5.21 -0.23 22.35*** 1.02 27.56*** 1.37
Borderline 38.57 (20.32) 47.53 (20.88) 19.04 (17.91) 27.99*** -8.98 -0.43 19.52*** 1.02 28.49*** 1.46
Paranoid 40.13 (25.22) 42.84 (25.73) 24.60 (24.84) 7.91*** -2.71 -0.11 15.53** 0.62 18.24*** 0.72
* p<.05; ** p<.01; *** p<.005; AS: Anxiety Sensitivity
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Discussion
 
The results obtained by several researchers in their quest to 
determine whether there are specifi c personality pathology profi les 
for PD/PDA are similar to those found in our study, which shows 
that the more frequent personality pathology profi les in the PD/PDA 
sample were avoidant, dependent and obsessive-compulsive (Albert 
et al., 2006; Iketani et al., 2004; Marchesi et al., 2005, 2006). 
The use of a non-clinical sample with high AS in the study 
of personality characteristics in patients with PD/PDA has not 
been included in any other study that we have reviewed; our work 
represents a contribution in this regard. No statistically signifi cant 
differences between PD/PDA and the high AS sample were found 
when using the MCMI-III. These results support the new proposals 
in the conceptualization and classifi cation of emotional disorders, 
which states that there are basic characteristics common to all, 
indicating a dimensional structure of the emotional disorders 
(Brown & Barlow, 2009). It could be that people belonging to the 
high AS sample share with the clinical group a vulnerability to 
suffer emotional disorders. If the characteristics of personality 
and AS were similar in both groups, we may have evaluated those 
individuals at a time when the disorder had not yet been activated. 
In our study, the high AS sample is younger than the clinical group, 
and it could be argued that the differences found between these 
groups could be explained by this age difference (maybe the high 
AS sample was too young to have developed PD/PDA). However, 
the studies that have attempted to fi nd clinical differences in PD/
PDA depending on the age of onset have used 18 (Seguí et al., 
1999), 20 (Goldstein, Wickramaratne, Horwath, & Weismann, 
1997) or 25 years old (Iketani et al., 2004) to determine the early 
or late onset of the disorder. Given that the mean age of the high 
AS sample is almost 27 years (26.9), we could say that they have 
exceeded the usual age of onset of PD/PDA. 
The similarity of personality characteristics between the 
two groups may indicate that the high AS sample could have 
“protective” factors for the development of the PD/PDA. If we 
consider the diathesis-stress models, in spite of having psychological 
vulnerability factors, stressful life events are necessary to develop 
a psychological disorder. Perhaps participants in our sample with 
high SA have not suffered major life stressors or have managed 
to deal with them through psychological (emotional regulation 
strategies) and social resources. It would be interesting to conduct 
a more extensive and detailed assessment of this sample to help 
identify which aspects make the difference between the high AS 
sample and the clinical sample. These fi ndings would be of great 
importance fi rst, to identify individuals at risk, second, to implement 
preventive programs, third, to help clinicians to improve the 
assessment and treatment protocols, and fi nally, to improve effi cacy 
and effectiveness of the clinical interventions for PD/PDA.
We found no signifi cant differences among the three groups 
regarding two personality pathology scales, Antisocial and 
Compulsive. From a dimensional perspective, it would not be 
surprising to obtain high scores on personality pathology in 
individuals without a diagnosis of personality disorder or Axis 
I disorders, because a more complete clinical assessment should 
consider other aspects such as interference, frequency, distress, 
number and intensity of symptoms or severity. It would be 
interesting to study whether specifi c personality pathology profi les 
appear more frequently in the normal population. If this option 
were true, we might consider whether some personality pathology 
traits may be being reinforced in our society, causing, on one hand, 
a higher prevalence of these disorders and, on the other, a growing 
standardization of them. For example, the promotion in our society 
of individualism, competitiveness or fast success could lead to 
histrionic, compulsive or narcissistic patterns of functioning that 
could somehow be socially supported. 
The scores obtained in the BSI indicated that the high AS sample 
presented a similar profi le of psychopathology than the PD/PDA 
group in all scales but Phobic Anxiety and Paranoid Ideation. PD/
PDA patients scored higher (p<.001) in phobic anxiety and lower 
(p<.05) in paranoid ideation. The Paranoid Ideation scale refers to 
feelings of distrust, suspicion, irritability, and delusions ideation. 
The Phobic Anxiety scale includes aspects such as panic attacks 
or intense fear associated with agoraphobic situations. This factor 
would essentially include symptoms related to PDA (APA, 1994). 
In view of these results, we could argue that moderate scores on 
the ASI failed to infl uence the phobic anxiety scores. These data 
support the idea that AS is a vulnerability factor, but there are 
other variables like phobic anxiety that could be a key element in 
the development of anxiety psychopathology. 
As hypothesized, participants with high AS not only presented 
one vulnerability factor for developing a emotional disorder such 
PD/PDA, that is AS (Schmidt et al., 2010; Weems et al., 2007), but 
they also presented another source of vulnerability, personality 
disorder traits. The neuroticism/negative affect construct raised 
by Brown and Barlow’s model (2009) is observed, according to 
Table 3
Means and standard deviations on normative data, means, standard deviations, mean differences (Tukey’s statistical), signifi cance and effect size on the Brief Symptom 
Inventory in the different study groups
Manª
Mean (SD)
Womanª
Mean (SD)
Clinical
PD/PDA
Non-clinical
High AS
Non-clinical
Low AS
PD/PDA–
High AS
PD/PDA–
Low AS
High AS–
Low AS
Mean (SD) Mean (SD) Mean (SD) F Difference d Difference d Difference d
Depression 6.04 (6.53) 7.68 (6.88) 10.55 (6.88) 11.69 (7.11) 4.67 (4.77) 17.98*** -1.14 -0.16 5.88*** 0.99 7.02*** 1.16
Phobic anxiety 1.37 (2.55) 2.47 (3.55) 10.57 (6.26) 4.08 (3.34) 0.69 (1.47) 74.32*** 6.49*** 1.29 9.89*** 2.17 3.39*** 1.31
Paranoid ideation 6.98 (6.16) 7.82 (6.52) 7.13 (5.08) 9.66 (6.37) 3.61 (3.41) 17.39*** -2.53* -0.44 3.52*** 0.81 6.05*** 1.18
Obsession-compulsion 6.56 (6.00) 7.83 (6.52) 12.19 (6.46) 12.00 (6.76) 4.69 (4.05) 28.23*** 0.19 0.03 7.50*** 1.39 7.31*** 1.31
Somatization 3.79 (3.64) 5.32 (4.02) 10.01 (5.48) 8.30 (4.51) 2.76 (2.41) 41.39*** 1.71 0.34 7.25*** 1.71 5.54*** 1.53
Hostility/Aggressivity 2.77 (2.89) 2.71 (3.04) 2.88 (3.31) 3.05 (3.34) 0.94 (1.64) 8.72*** -0.17 -0.05 1.94*** 0.74 2.11*** 0.8
ª Reported by Ruipérez et al. (2001); * p<.05; ** p<.01; *** p<.005; AS: Anxiety Sensitivity
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this preliminary work, not only in PD/PDA patients, but also 
in people with no diagnosis on Axis I or II but with a similar 
psychopathology profi le, characterized specially by: (a) high scores 
on the ASI, (b) high scores on depression, obsession, and paranoid 
psychopathology scales of BSI, and (c) avoidant, dependent and 
narcissistic personality traits. Other studies will be required, with 
clinical and larger high AS samples, to confi rm the preliminary 
results presented in this paper. In addition, it will require more 
comprehensive assessment of high AS samples to identify 
protective factors that prevent the onset of PD/PDA disorders. 
Finally, this research should include longitudinal studies that 
prove that the vulnerability factors identifi ed in high AS samples 
trigger the onset of PD/PDA disorders and whether preventive 
interventions could prevent the activation of psychopathological 
processes related to anxiety that trigger a PD/PDA disorder.
This study has some limitations. First, the small sample size of 
the different samples and the differences observed in demographic 
factors suggest caution in the generalization of our results. Second, 
it would be necessary to evaluate the absence of Axis I disorders 
with clinical structured interviews such as the ADIS-IV in the 
non-clinical samples. Finally, it would be interesting to conduct 
a more extensive and detailed assessment of the non-clinical 
samples to help identify which aspects make a difference between 
the high AS sample and the clinical sample.
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